Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;176(2):275-82.
doi: 10.1111/cei.12262.

Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients

C Chopra  1 , G Davies, M Taylor, M Anderson, S Bainbridge, P Tighe, E M McDermott
Affiliations

Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients

C Chopra et al. Clin Exp Immunol. 2014 May.

Abstract

Ataxia-Telangiectasia (A-T) is a genetic condition leading to neurological defects and immune deficiency. The nature of the immune deficiency is highly variable, and in some cases causes significant morbidity and mortality due to recurrent sinopulmonary infections. Although the neurological defects in A-T are progressive, the natural history of the immune deficiency in A-T has not been evaluated formally. In this study we analyse the clinical history and immunological data in 44 patients with A-T who attended the National Ataxia-Telangiectasia clinic in Nottingham between 2001 and 2011. Using patient medical records and Nottingham University Hospitals (NUH) National Health Service Trust medical IT systems, data regarding clinical history, use of immunoglobulin replacement therapy, total immunoglobulin levels, specific antibody levels and lymphocyte subset counts were obtained. T cell receptor spectratyping results in some patients were already available and, where possible, repeat blood samples were collected for analysis. This study shows that subtle quantitative changes in certain immunological parameters such as lymphocyte subset counts may occur in patients with A-T over time. However, in general, for the majority of patients the severity of immune deficiency (both clinically and in terms of immunological blood markers) does not seem to deteriorate significantly with time. This finding serves to inform the long-term management of this cohort of patients because, if recurrent respiratory tract infections present later in life, then other contributory factors (e.g. cough/swallowing difficulties, underlying lung disease) should be investigated aggressively. Our findings also offer some form of reassurance for parents of children with A-T, which is otherwise a progressively severely debilitating condition.

Keywords: Ataxia-Telangiectasia; immune deficiency; infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trend over time in total immunoglobulin (Ig)G levels in 35 patients with A-T.
Figure 2
Figure 2
Trend in number of normal TCR V beta usage in patients with A-T.
See this image and copyright information in PMC

References

    1. McKinnon PJ. ATM and the molecular pathogenesis of Ataxia-Telangiectasia. Annu Rev Pathol. 2012;7:301–321. - PubMed
    1. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14:197–210. - PubMed
    1. McConville C, Stankovic T, Byrd PJ, et al. Mutations associated with variant phenotypes in Ataxia-telangiectasia. Am J Hum Genet. 1996;59:320–330. - PMC - PubMed
    1. Stewart GS, Last JI, Stankovic T, et al. Residual Ataxia-Telangiectasia mutated protein function in cells from Ataxia-Telangiectasia patients, with 5762ins137 and 7271T – >G mutations, showing a less severe phenotype. J Biol Chem. 2001;276:30133–30141. - PubMed
    1. Staples ER, McDermott EM, Reiman A, et al. Immunodeficiency in Ataxia-Telangiectasia is correlated strongly with the presence of two null mutations in the Ataxia-Telangiectasia mutated gene. Clin Exp Immunol. 2008;153:214–220. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts